Tuberculosis screening in multiple sclerosis: effect of disease-modifying therapies and lymphopenia on the prevalence of indeterminate TB screening results in the clinical setting

BACKGROUND: Tuberculosis screening is recommended in multiple sclerosis patients starting certain disease-modifying therapies. Disease-modifying therapies may affect interferon-gamma release assay results. OBJECTIVE: To determine the effects of multiple sclerosis disease-modifying therapies on inter...

Descripción completa

Detalles Bibliográficos
Autores principales: Baldassari, Laura E, Feng, Jenny, Macaron, Gabrielle, Planchon, Sarah M, Alshehri, Ebtesam, Moss, Brandon P, Ontaneda, Daniel, Willis, Mary A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6740049/
https://www.ncbi.nlm.nih.gov/pubmed/31588362
http://dx.doi.org/10.1177/2055217319875467

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6740049/
https://www.ncbi.nlm.nih.gov/pubmed/31588362
http://dx.doi.org/10.1177/2055217319875467

Ejemplares similares